Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Migraine

Free Subscription 06.06.2022 1 BMC Neurol 4 Cephalalgia 1 Neurol Genet

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. MAGDY R, Eid RA, Hassan M, Abdelghaffar M, et al
   The potential impact of nutritional intake on symptoms severity in patients with comorbid migraine and irritable bowel syndrome.
   BMC Neurol. 2022;22:199.
   PubMed         Abstract available
   
   

   
   Cephalalgia

2. SUDAT SE, Jacobson AS, Avins AL, Lipton RB, et al
   A population-health approach to characterizing migraine by comorbidity: Results from the Mindfulness and Migraine Cohort Study.
   Cephalalgia. 2022 May 31:3331024221104180. doi: 10.1177/03331024221104180.
   PubMed         Abstract available
   
   
3. CHRISTENSEN CG, Techlo TR, Kogelman LJ, Wegner Thorner L, et al
   Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria.
   Cephalalgia. 2022 May 29:3331024221094548. doi: 10.1177/03331024221094548.
   PubMed         Abstract available
   
   
4. EVERS S, Frese A, Summ O, Husstedt IW, et al
   Levetiracetam in the prophylactic treatment of episodic migraine: A prospective open label study.
   Cephalalgia. 2022 May 27:3331024221103815. doi: 10.1177/03331024221103815.
   PubMed         Abstract available
   
   
5. MOUAANAKI SA, Carlsen LN, Bendtsen L, Jensen RH, et al
   Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center.
   Cephalalgia. 2022 May 27:3331024221104178. doi: 10.1177/03331024221104178.
   PubMed         Abstract available
   
   

   
   Neurol Genet

6. 
   Erratum: Migraine, Stroke, and Cervical Arterial Dissection: Shared Genetics for a Triad of Brain Disorders With Vascular Involvement.
   Neurol Genet. 2022;8:e675.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: